Conversely, the downregulation of NFS1, GCLC, TP63, CD44, and SRC suggests a potential attenuation of antioxidant defense systems, thereby predisposing tumor cells to lipid peroxidation-mediated cell death. The gene discussed is SRC; the disease is neoplasm.